Shikari® (S-ATPAL) Anti-Palivizumab ELISA
Enzyme immunoassay for the qualitative determination of specific antibodies to Palivizumab (Synagis®) in serum and plasma.
This kit has been especially developed for the qualitative determination of specific antibodies to palivizumab in serum and plasma samples.
The Matriks Biotek Antibody to Palivizumab (Synagis®) Enzyme-Linked-ImmunoSorbentAssay (ELISA) Kit is intended for the qualitative determination of antibodies to Palivizumab (Synagis®) in serum and plasma. It is for professional use only. Measurement of biological drug trough levels and antibody to biological drug gained high importance during the course of treatment. These measurements enable dose adjustments and switch to another class of biological drug when necessary.
All SHIKARI® ELISA kits are suitable for biosimilar work.
All SHIKARI® ELISA kits are produced under ISO 13485 quality system and have CE IVD mark.
For technical inquiry, please contact email@example.com
|Required Volume (µl)||20|
|Total Time (min)||140|
|Detection Limit (ng/mL)||+ / -|
|Spike Recovery (%)||-|
|Shelf Life (year)||1|
|Storage conditions||Store at +4°C. Please refer to protocols.|
|Shipping conditions||At room temperature|